Nadine Schulz

645 total citations
7 papers, 501 citations indexed

About

Nadine Schulz is a scholar working on Molecular Biology, Plant Science and Hepatology. According to data from OpenAlex, Nadine Schulz has authored 7 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Plant Science and 2 papers in Hepatology. Recurrent topics in Nadine Schulz's work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Metabolomics and Mass Spectrometry Studies (1 paper) and Cancer Mechanisms and Therapy (1 paper). Nadine Schulz is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Metabolomics and Mass Spectrometry Studies (1 paper) and Cancer Mechanisms and Therapy (1 paper). Nadine Schulz collaborates with scholars based in Germany, Austria and India. Nadine Schulz's co-authors include Carla Klattenhoff, Soohyun Lee, Monika Syrzycka, Hualin Simon Xi, Hervé Seitz, Barry M. Honda, Chengjian Li, Zhiping Weng, Maria L. Zapp and Vasily V. Vagin and has published in prestigious journals such as Cell, International Journal of Molecular Sciences and Journal of Chromatography A.

In The Last Decade

Nadine Schulz

7 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadine Schulz Germany 5 421 358 52 51 19 7 501
Yujie Fan China 11 384 0.9× 89 0.2× 27 0.5× 79 1.5× 38 2.0× 41 516
Zhenping Liu China 14 359 0.9× 336 0.9× 24 0.5× 45 0.9× 21 1.1× 27 608
Jordi Xiol France 4 491 1.2× 360 1.0× 37 0.7× 86 1.7× 21 1.1× 4 553
Martin Fabry United Kingdom 4 460 1.1× 299 0.8× 79 1.5× 50 1.0× 19 1.0× 4 524
Sundaresan Tharun United States 12 972 2.3× 89 0.2× 38 0.7× 46 0.9× 22 1.2× 15 1.0k
Cansu Colpan United States 11 508 1.2× 339 0.9× 81 1.6× 79 1.5× 20 1.1× 11 569
Songbo Wang China 10 323 0.8× 221 0.6× 108 2.1× 103 2.0× 20 1.1× 30 521
Eri Sakota Japan 6 415 1.0× 277 0.8× 30 0.6× 41 0.8× 10 0.5× 7 444
Adam N. Harris United States 2 370 0.9× 203 0.6× 40 0.8× 82 1.6× 12 0.6× 4 434
Zhenzhen Yang China 11 269 0.6× 337 0.9× 40 0.8× 39 0.8× 16 0.8× 27 531

Countries citing papers authored by Nadine Schulz

Since Specialization
Citations

This map shows the geographic impact of Nadine Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadine Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadine Schulz more than expected).

Fields of papers citing papers by Nadine Schulz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadine Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadine Schulz. The network helps show where Nadine Schulz may publish in the future.

Co-authorship network of co-authors of Nadine Schulz

This figure shows the co-authorship network connecting the top 25 collaborators of Nadine Schulz. A scholar is included among the top collaborators of Nadine Schulz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadine Schulz. Nadine Schulz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Naß, Norbert, Christian Wybranski, Nadine Schulz, et al.. (2017). Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro. Anticancer Research. 37(1). 87–94. 12 indexed citations
2.
Schulz, Nadine, Hassan Chaachouay, Katarzyna J. Nytko, et al.. (2017). Dynamic In Vivo Profiling of DNA Damage and Repair after Radiotherapy Using Canine Patients as a Model. International Journal of Molecular Sciences. 18(6). 1176–1176. 10 indexed citations
3.
Seidensticker, Max, Norbert Naß, Christian Wybranski, et al.. (2016). Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model. Diagnostic and Interventional Radiology. 22(4). 378–384. 8 indexed citations
4.
Li, Chengjian, Vasily V. Vagin, Soohyun Lee, et al.. (2009). Collapse of Germline piRNAs in the Absence of Argonaute3 Reveals Somatic piRNAs in Flies. Cell. 137(3). 509–521. 444 indexed citations
5.
Oufir, Mouhssin, Nadine Schulz, Eva Wilhelm, et al.. (2008). Simultaneous measurement of proline and related compounds in oak leaves by high-performance ligand-exchange chromatography and electrospray ionization mass spectrometry for environmental stress studies. Journal of Chromatography A. 1216(7). 1094–1099. 25 indexed citations
6.
Schulz, Nadine, et al.. (2006). CIGR Handbook of Agricultural Engineering Volume VI Information Technology, Axel Murnack (Ed.). 1 indexed citations
7.
Schmitt, Ingo, et al.. (2005). WS-QBE: Eine QBE-Anfragesprache für komplexe Ähnlichkeitsanfragen.. Künstliche Intell.. 19. 44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026